Hui Shao
Directeur/Bestuurslid bij Hangzhou Adlai Nortye Biopharma Co. Ltd.
Profiel
Hui Shao currently works at Hangzhou Adlai Nortye Biopharma Co. Ltd., as Non-Executive Director from 2020 and Adlai Nortye USA, Inc., as Director from 2020.
Mr. Shao also formerly worked at Adlai Nortye Ltd., as Non-Executive Director.
Mr. Shao received his undergraduate degree in 1993 from Northeast Normal University.
Actieve functies van Hui Shao
| Bedrijven | Functie | Begin |
|---|---|---|
Hangzhou Adlai Nortye Biopharma Co. Ltd.
 Hangzhou Adlai Nortye Biopharma Co. Ltd. BiotechnologyHealth Technology Part of Adlai Nortye Ltd., Hangzhou Adlai Nortye Biopharma Co. Ltd. is a clinical-stage biopharmaceutical company based in Hangzhou, China. Adlai Nortye is developing differentiated, innovative immuno-oncology medicines with a focus on discovering and developing important new treatments for cancer. The Chinese company's mission is to improve patient lives by identifying and developing differentiated innovative medicines that help people live better and longer. The company was founded in 2004 by Yang Lu, Dong Hui Yang, and Yang Lu has been the CEO since then. | Directeur/Bestuurslid | 01-02-2020 |
| Adlai Nortye USA, Inc. | Directeur/Bestuurslid | 01-01-2020 |
Eerdere bekende functies van Hui Shao
| Bedrijven | Functie | Einde |
|---|---|---|
| ADLAI NORTYE LTD. | Directeur/Bestuurslid | - |
Opleiding van Hui Shao
| Northeast Normal University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ADLAI NORTYE LTD. | Commercial Services |
| Bedrijven in privébezit | 2 |
|---|---|
Hangzhou Adlai Nortye Biopharma Co. Ltd.
Hangzhou Adlai Nortye Biopharma Co. Ltd. BiotechnologyHealth Technology Part of Adlai Nortye Ltd., Hangzhou Adlai Nortye Biopharma Co. Ltd. is a clinical-stage biopharmaceutical company based in Hangzhou, China. Adlai Nortye is developing differentiated, innovative immuno-oncology medicines with a focus on discovering and developing important new treatments for cancer. The Chinese company's mission is to improve patient lives by identifying and developing differentiated innovative medicines that help people live better and longer. The company was founded in 2004 by Yang Lu, Dong Hui Yang, and Yang Lu has been the CEO since then. | Health Technology |
| Adlai Nortye USA, Inc. |
